{
    "data": [
        {
            "id": "69a1bc8224c37e0001bc0cfa",
            "title": "Energy Fuels Stock Falls Despite Revenue Beat, Strong Guidance",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Energy Fuels Inc</strong> <a class=\"ticker-link\" data-exchange=\"NYSEARCA\" data-ticker=\"UUUU\" href=\"https://www.benzinga.com/quote/UUUU\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/UUUU\" target=\"_blank\">UUUU</a>)<!-- --> shares are trading lower on Friday after the uranium and rare earths producer posted fourth-quarter results that matched Wall Street profit forecasts while topping revenue expectations. Here’s what investors <a href=\"https://www.benzinga.com/pressreleases/26/02/n50917312/energy-fuels-announces-2025-results-and-2026-guidance\" target=\"_blank\">need to know</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Energy Fuels stock is off session lows. <a href=\"https://www.benzinga.com/quote/UUUU\" rel=\"noreferrer noopener\" target=\"_blank\">Why is UUUU stock volatile?</a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Quarterly Loss Narrows, Revenue Beats Estimates</h2><!--/$--><!--$--><p class=\"block core-block\">The company <a href=\"https://www.benzinga.com/quote/UUUU/earnings\" target=\"_blank\">reported</a> a fourth-quarter net loss of 9 cents per share, in line with analyst estimates and an improvement from a 19-cent loss a year earlier.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue came in at $27.1 million, beating the $21.8 million consensus but falling about 32% from the prior-year quarter as sales volumes declined.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Guidance Highlights Uranium, Rare Earths Growth</h2><!--/$--><!--$--><p class=\"block core-block\">Alongside the quarter, Energy Fuels released full-year 2025 results and 2026 guidance, emphasizing its position as a leading U.S. uranium producer and an emerging player in rare earth elements. </p><!--/$--><!--$--><p class=\"block core-block\">Management <a href=\"https://www.benzinga.com/pressreleases/26/02/n50917312/energy-fuels-announces-2025-results-and-2026-guidance\" target=\"_blank\">highlighted</a> more than $900 million in working capital, including cash, marketable securities and inventories, supported in part by a recent $700 million convertible notes offering.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">For 2025, the company generated about $48 million in uranium revenue, selling 650,000 pounds of U₃O₈ at an average realized price in the mid-$70s per pound, while mining over 1.7 million pounds of contained uranium for future deliveries.</p><!--/$--><!--$--><p class=\"block core-block\">Looking ahead to 2026, Energy Fuels expects higher uranium production and sales volumes as it ramps output from its U.S. mines and continues investing in rare earth processing capabilities.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">UUUU Stock Maintains Long-Term Uptrend</h2><!--/$--><!--$--><p class=\"block core-block\">Energy Fuels shares have climbed 450% over the past year, rising from around $4 to the low-$20s, with notable volatility and a peak near $27.72 before pulling back. </p><!--/$--><!--$--><p class=\"block core-block\">Despite fluctuations, the overall trend remains upward, supported by rising short- and long-term moving averages.</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">UUUU Shares Edge Lower Friday Morning</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>UUUU Price Action:</strong> Energy Fuels shares were down 2.98% at $22.17 at the time of publication on Friday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50932165\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Periodic-Table-Concept-With-Black-Cubes-.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50932165/energy-fuels-stock-falls-despite-revenue-beat-strong-guidance",
            "pub_date": "2026-02-27 23:47:17",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1be5324c37e0001bc0ed2",
            "title": "Archer&#39;s Midnight Air Taxis To Feature Musk&#39;s Starlink",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Archer Aviation</strong> <strong>Inc. </strong><a href=\"https://www.benzinga.com/quote/ACHR\" rel=\"noreferrer noopener\" target=\"_blank\"></a><a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"ACHR\" href=\"https://www.benzinga.com/quote/ACHR\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/ACHR\" target=\"_blank\">ACHR</a>)<!-- --> announced on Friday that it has partnered with <strong>Elon Musk’s Starlink </strong>to<a href=\"https://www.benzinga.com/pressreleases/26/02/b50925411/industry-first-archer-to-bring-starlink-onboard-midnight-air-taxis\" rel=\"noreferrer noopener\" target=\"_blank\"> deliver high-speed satellite connectivity</a> to its Midnight electric air taxi, marking Starlink’s first move into urban air mobility.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Starlink Onboard Midnight Air Taxis</h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Under the deal, Archer will install Starlink’s low-Earth-orbit (LEO) satellite system into Midnight — engineered to deliver consistent, high-speed coverage at low altitudes and in dense urban environments where traditional connectivity solutions fall short.</p><!--/$--><!--$--><p class=\"block core-block\">Beyond passenger internet access, the integration will strengthen pilot-to-ground communications and lay the groundwork for Archer’s future autonomous aircraft development — a move that could reshape the urban air mobility sector entirely.</p><!--/$--><!--$--><p class=\"block core-block\">Midnight is Archer’s electric air taxi, seating four passengers, featuring 12 redundant engines for airliner-level safety, with city crossings targeted in just 5-15 minutes.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Adam Goldstein</strong>, founder and CEO of Archer, commented, “Connectivity is a must have feature for Midnight. Starlink is uniquely built to deliver it. This industry-first collaboration will enable seamless, high-speed connectivity and essential amenities for our passengers and pilots.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Stock Performance</h2><!--/$--><!--$--><p class=\"block core-block\">Over the past year, Archer Aviation has seen its stock price decline by 6.82%. Currently, the stock is trading at $7.17, which is 1.4% above its 20-day SMA but significantly below its longer-term averages: 8.2% below the 50-day SMA and 24.4% below the 200-day SMA. This positioning suggests a bearish trend over the medium to long term, despite recent gains above the shortest of these averages.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The technical indicators present a mixed outlook. The RSI stands at 49.85, indicating a neutral market momentum, neither overbought nor oversold. However, the MACD presents a more optimistic view, signaling bullish momentum as it is currently above the signal line, suggesting near-term upward price momentum.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Upcoming Earnings</h2><!--/$--><!--$--><p class=\"block core-block\">Archer Aviation is set to report earnings on March 2, 2026. With the earnings date rapidly approaching, here is what investors and analysts are anticipating:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>EPS Estimate</strong>: Loss of 20 cents (Up from a loss of 45 cents YoY)</li>\n<li><strong>Revenue Estimate</strong>: 67 cents million (Up from 0 cents million YoY)</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Consensus &amp; Recent Actions:</strong> The stock carries a Buy Rating with an <a href=\"https://www.benzinga.com/quote/ACHR/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">average price target</a> of $11.09. Recent analyst moves include:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Needham</strong>: Buy (Maintains Target to $10.00) (Jan. 14)</li>\n<li><strong>Goldman Sachs</strong>: Initiated with Neutral (Target $11.00) (Dec. 1, 2025)</li>\n<li><strong>Canaccord Genuity</strong>: Buy (Raises Target to $13.00) (Nov. 21, 2025)</li>\n</ul><!--/$--><!--$--><h2 class=\"wp-block-heading\">Benzinga Edge Scorecard</h2><!--/$--><!--$--><p class=\"block core-block\">Below is the <a href=\"https://www.benzinga.com/screener\" rel=\"noreferrer noopener\" target=\"_blank\">Benzinga Edge scorecard</a> for Archer Aviation, highlighting its strengths and weaknesses compared to the broader market:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Momentum Rank</strong>: 14.32 — This score indicates weak performance, suggesting that the stock is underperforming the broader market significantly.</li>\n</ul><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>The Verdict:</strong> Archer Aviation’s Benzinga Edge signals a challenging market position, with a low Momentum score of 14.32 — making strategic moves like the Starlink partnership critical to reinvigorating investor interest.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">ACHR’s Impact on Key ETFs</h2><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Significance:</strong> Because ACHR carries significant weight in these funds, any significant inflows or outflows will likely trigger automatic buying or selling of the stock.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>ACHR Price Action:</strong> Archer Aviation shares were down 4.52% at $7.04 at the time of publication on Friday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50932564\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/San-Jose--California-Us---February-14--2.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50932564/archers-midnight-air-taxis-to-feature-musks-starlink",
            "pub_date": "2026-02-27 23:55:03",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1bc2424c37e0001bc0c7a",
            "title": "Here&#39;s How Much You Would Have Made Owning General Dynamics Stock In The Last 5 Years",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">General Dynamics (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GD\" target=\"_blank\">GD</a>) has outperformed the market over the past 5 years by 3.78% on an annualized basis producing an average annual return of 15.88%. Currently, General Dynamics has a market capitalization of $95.71 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $100 In GD:</strong> If an investor had bought $100 of GD stock 5 years ago, it would be worth <strong>$209.74</strong> today based on a price of $353.98 for GD at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">General Dynamics's Performance Over Last 5 Years</h3><!--/$--><!--$?--><template id=\"B:1\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/26/02/50932060/heres-how-much-you-would-have-made-owning-general-dynamics-stock-in-the-last-5-years",
            "pub_date": "2026-02-27 23:45:44",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1bc2724c37e0001bc0c7e",
            "title": "OneMedNet Stock Skyrockets As It Rolls Out Next RWD Phase With Palantir Foundry",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>OneMedNet</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"ONMD\" href=\"https://www.benzinga.com/quote/ONMD\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/ONMD\" target=\"_blank\">ONMD</a>)<!-- --> shares are up on Friday following the company’s announcement of <a href=\"https://www.benzinga.com/pressreleases/26/02/g50926140/onemednet-announces-next-phase-of-commercial-launch-with-its-real-world-data-rwd-platform-powered-\" target=\"_blank\">the next phase</a> of its commercial launch for its Real-World Data (RWD) platform, which is powered by <strong>Palantir Technologies Inc.’s </strong><a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"PLTR\" href=\"https://www.benzinga.com/quote/PLTR\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/PLTR\" target=\"_blank\">PLTR</a>)<!-- --> Foundry.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>      • OneMedNet stock is charging ahead with explosive momentum. <a href=\"https://www.benzinga.com/quote/ONMD\" rel=\"noreferrer noopener\" target=\"_blank\">Why are ONMD shares rallying?</a></strong></p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">This development is contributing to a positive sentiment around the stock, even as broader markets are experiencing declines, with the S&amp;P 500 down 0.96%.</p><!--/$--><!--$--><p class=\"block core-block\">“Customer feedback has reinforced the platform’s performance, speed, and depth of discovery,” said CEO <strong>Aaron Green</strong>. “We believe this traction validates our strategy of combining conversational AI-driven search with scalable, prospective data feeds, strengthening customer confidence as we expand subscriptions and deliver fast, intuitive value for Real-World evidence generation.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Trials To Subscriptions</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The company is actively converting customer evaluations into commercial subscriptions, which are expected to drive predictable growth and millions in “incremental” annual recurring revenue (ARR). </p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">With over 2,130 healthcare sites integrated into its iRWD platform, OneMedNet is set to enhance its subscription value through greater scale and real-time access to comprehensive regulatory-grade multimodal data.</p><!--/$--><!--$--><p class=\"block core-block\">The launch is expected to accelerate the adoption of its platform across life sciences and AI health innovators, providing customers with near real-time access to integrated clinical and longitudinal datasets. This strategic move aims to streamline workflows and enhance the speed of evidence generation, reinforcing OneMedNet’s position in the healthcare data landscape.</p><!--/$--><!--$--><p class=\"block core-block\">The broader market is experiencing a mixed day, with major indices like the Dow Jones down 1.41% and the Nasdaq down 0.90%. Despite this, the health care sector is showing some resilience, with a modest gain of 0.26%, indicating that OneMedNet’s positive news may be resonating well within this sector.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Technical Analysis</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The stock is currently trading 12.5% below its 20-day simple moving average (SMA) and 20% below its 100-day SMA, indicating some short-term weakness. Over the past 12 months, shares have decreased significantly, reflecting broader market challenges, and are currently positioned closer to their 52-week lows than highs.</p><!--/$--><!--$--><p class=\"block core-block\">The RSI is at 50.00, which is considered neutral territory, suggesting the stock is neither overbought nor oversold at this time. Meanwhile, MACD is at 0.10, below its signal line at 0.15, indicating bearish pressure on the stock.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The combination of neutral RSI and bearish MACD suggests mixed momentum, indicating that traders should watch for potential shifts in market sentiment.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Key Resistance</strong>: $1.50</li>\n<li><strong>Key Support</strong>: 75 cents</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Consensus &amp; Recent Actions:</strong> The stock carries a N/A Rating. No recent analyst actions available.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>ONMD Price Action:</strong> OneMedNet shares were up 81.46% at $1.28 at the time of publication on Friday, according to <a href=\"https://pro.benzinga.com/dashboard\" target=\"_blank\">Benzinga Pro data</a>.</p><!--/$--><!--$--><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50932062\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Stock-Market-Graph-Trading-Analysis-Inve.jpeg",
            "link": "https://www.benzinga.com/markets/equities/26/02/50932062/onemednet-stock-skyrockets-as-it-rolls-out-next-rwd-phase-with-palantir-foundry",
            "pub_date": "2026-02-27 23:45:47",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1b8ab24c37e0001bc08e7",
            "title": "If You Invested $100 In AstraZeneca Stock 5 Years Ago, You Would Have This Much Today",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">AstraZeneca (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AZN\" target=\"_blank\">AZN</a>) has outperformed the market over the past 5 years by 4.19% on an annualized basis producing an average annual return of 16.3%. Currently, AstraZeneca has a market capitalization of $321.64 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $100 In AZN:</strong> If an investor had bought $100 of AZN stock 5 years ago, it would be worth <strong>$211.72</strong> today based on a price of $207.47 for AZN at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">AstraZeneca's Performance Over Last 5 Years</h3><!--/$--><!--$?--><template id=\"B:1\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/26/02/50931183/if-you-invested-100-in-astrazeneca-stock-5-years-ago-you-would-have-this-much-today",
            "pub_date": "2026-02-27 23:30:56",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}